B7-H4

B7-H4

B7-H4 분자 정보

Molecule Name
V-set domain-containing T-cell activation inhibitor 1
분자 별명
B7-H4,VTCN1,B7S1,B7h.5
Drug Development Progress
임상 약물 수11
시판 약물 수0
최고 연구 개발 단계Phase 3 Clinical
표적 별명
V-Set Domain-Containing T-Cell Activation Inhibitor 1,Immune costimulatory protein B7-H4,B7h.5,B7 homolog 4,T-cell costimulatory molecule B7x,V-Set Domain Containing T Cell Activation Inhibitor 1,B7X,B7 Family Member, H4,T Cell Costimulatory Molecule B7x,B7S1,B7 Superfamily Member 1,VCTN1,PRO1291,FLJ22418,B7H4,B7-H4,Protein B7S1
분자 배경
V-set domain-containing T-cell activation inhibitor 1 (VTCN1) is also known as Immune costimulatory protein B7-H4, Protein B7S1, T-cell costimulatory molecule B7x, B7H4, which belongs to the immunoglobulin superfamily and BTN/MOG family. VTCN1 contains two Ig-like V-type (immunoglobulin-like) domains. The expression of VTCN1 is up-regulated by IL6 and IL10 and is inhibited by GM-CSF and IL4 on antigen-presenting cells (APCs). VTCN1 / B7-H4 negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. VTCN1 involved in promoting epithelial cell transformation.

B7-H4 제품 목록

Species
  • Human(4)
  • Mouse(3)
  • Cynomolgus / Rhesus macaque(2)
  • Canine(1)
  • Rat(1)
Tag
  • His Tag(7)
  • His Tag & Avi Tag(3)
  • Fc Tag(1)
Host
  • HEK293(11)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(4)
  • Azide Labeled(1)
Grade
  • RUO(11)
Low Endotoxin
  • Yes(5)
  • No(6)
You Have Viewed 1-10 Of 11 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Puxitatug SamrotecanAZD8205; AZD-8205Phase 3 ClinicalAstrazeneca Plc
Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
Mocertatug RezetecanHS-20089; GSK-5733584; GSK5733584Phase 3 ClinicalShanghai Hansoh Biomedical Co Ltd
Breast Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
ABL-103ABL-103Phase 2 ClinicalAbl Bio Inc, Handok Inc
Solid tumours
상세
MHB-009CMHB-009C; MHB009CPhase 2 ClinicalMinghui Pharmaceutical (Hangzhou) Co Ltd
Solid tumours
상세
GEN-1047GEN-1047Phase 2 ClinicalGenmab A/S
Endometrial Neoplasms
상세
DB-1312BG-C9074; DB-1312Phase 1 ClinicalDuality Biologics (Suzhou) Co Ltd
Solid tumours
상세
LNCB-74LNCB-74; LNCB74; LCB41APhase 1 ClinicalLigaChem Biosciences Inc, Nextcure Inc
Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Neoplasms; Ovarian Neoplasms; Solid tumours
상세
XKH-002XKH-002; XKH002Phase 1 ClinicalBeijing Kanova Biomedical Technology Co Ltd, Zhejiang Kanova Biopharmaceutical Co Ltd
Neoplasms; Solid tumours
상세
Felmetatug vedotinSGN-B7H4V; PF-08046048; SGN-B-7H-4V; SGNB-7H4V; SGNB-7H-4VPhase 1 ClinicalSeagen Inc
Breast Neoplasms; Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gallbladder Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
Emiltatug LedadotinXMT-1660Phase 1 ClinicalMersana Therapeutics Inc
Abdominal Neoplasms; Breast Neoplasms; Carcinoma, Adenoid Cystic; Endometrial Neoplasms; Fallopian Tube Neoplasms; Neoplasms; Ovarian Neoplasms; Triple Negative Breast Neoplasms
상세
HBM-7008HBM7008; HBM-7008; R-7008; CLN-418Phase 1 ClinicalHarbour Biomed
Solid tumours
상세
Customer Reviews
  • 1***12019-11-16
    We purchased total of 600ug of this biotin-labeled antigen for liquid phase panning and antibody screening of affinity maturation. This antigen has good stability, high quality, and high repeatability for each experiment. Using this antigen, we screened high-affinity antibodies against this target. And using this antigen for screening of affinity maturation, we obtained antibodies with 10-times increased affinity. I highly recommended this product.